WuXi Presents 2013 Life Science and Chemistry Awards

We are delighted to announce that the seventh annual WuXi PharmaTech Life Science and Chemistry Awards ceremony was successfully held on December 7, 2013, at Diaoyutai State Guesthouse in Beijing. Fifteen...

WuXi Partners with Pharmacyclics

Shanghai SynTheAll (STA) Pharmaceutical Co., Ltd., WuXi’s STA, WuXi’s wholly owned subsidiary of small molecule process R&D and manufacturing division, has entered into a supply arrangement with Pharmacyclics, Inc. (Nasdaq: PCYC)....

WuXi Teams with Mayo Clinic’s Center for Individualized Medicine to Support Personalized Medicine Discovery

Biomedical research has witnessed dramatic breakthroughs in the genetic roots of disease, the underlying mechanisms of disease progression, and treatment response. Towards building a clearer picture of how systems interact and...

WuXi Oncology Receives Award for “Most Valuable Team Player ” from Genentech

We are honored to receive the Award for "Most Valuable Team Player" from Genentech in October 2013, in recognition of the contribution of the Oncology team in accelerating key deliveries with...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Harvard’s David Sinclair Treats Aging as a Disease and Plans to...

Harvard University’s David Sinclair, world renowned for his anti-aging research, sees no limit on human life span and is collaborating on a clinical trial...